[Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004873:Ergolines / Q000008:administration & dosage* / Q000627:therapeutic use*; D006801:Humans; D007269:Injections, Intra-Arterial; D007866:Leg / Q000098:blood supply; D009530:Nicergoline / Q000008:administration & dosage* / Q000627:therapeutic use*; D011928:Raynaud Disease / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D004873:Ergolines; D014665:Vasodilator Agents; D009530:Nicergoline
Sulla sperimentazione clinica di un nuovo farmaco vasoattivo F.I. 6714 somministrato per endoarteria nelle vasculopatie periferiche